Ivermectin: pharmacology and therapeutic applications
Journal: International Journal of Basic & Clinical Pharmacology (Vol.1, No. 3)Publication Date: 2012-12-01
Authors : Sunita B. Chhaiya Dimple S. Mehta Bhaven C. Kataria;
Page : 132-139
Keywords : Antiparasitic; Onchocerciasis; Strongyloidiasis; Scabies; Trichuris trichiura; Filariasis;
Abstract
Ivermectin is an antiparasitic drug with a broad spectrum of activity, high ef?cacy as well as a wide margin of safety. It belongs to the family of avermectins. It binds to glutamate-gated chloride iron channels, which are present in invertebrate nerve and muscle cells, and causes the paralysis and death of the parasite. Ivermectin is approved by the US Food and Drug Administration, and used worldwide to treat patients with onchocerciasis and strongyloidiasis. It is also used against a wide range of endoparasites (nematodes) and ectoparasites (insects, acarine) of animals and humans. [Int J Basic Clin Pharmacol 2012; 1(3.000): 132-139]
Other Latest Articles
- Chemotherapy induced nausea AND vomiting (CINV)
- Character localization and recognition application for Smartphone
- RECENT ADVANCES IN MICROSPHERE AS AN NOVEL DRUG DELIVERY SYSTEM A REVIEW
- REVIEW ON: GASTRORETENTIVE DRUG DELIVERY SYSTEM
- SINGLE AND MULTIPARTICULATE FLOATING DRUG DELIVERY SYSTEM: AN UPDATED REVIEW
Last modified: 2013-03-02 19:26:08